Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid benzylidene-carbohydrazide series

Bioorg Med Chem. 2009 Jan 1;17(1):295-302. doi: 10.1016/j.bmc.2008.10.085. Epub 2008 Nov 5.

Abstract

Chagas disease (American trypanosomiasis) is one of the most important parasitic diseases with serious social and economic impacts mainly on Latin America. This work reports the synthesis, in vitro trypanocidal evaluation, cytotoxicity assays, and molecular modeling and SAR/QSAR studies of a new series of N-phenylpyrazole benzylidene-carbohydrazides. The results pointed 6k (X=H, Y=p-NO2, pIC(50)=4.55 M) and 6l (X=F, Y=p-CN, pIC(50)=4.27 M) as the most potent derivatives compared to crystal violet (pIC(50)=3.77 M). The halogen-benzylidene-carbohydrazide presented the lowest potency whereas 6l showed the most promising profile with low toxicity (0% of cell death). The best equation from the 4D-QSAR analysis (Model 1) was able to explain 85% of the activity variability. The QSAR graphical representation revealed that bulky X-substituents decreased the potency whereas hydrophobic and hydrogen bond acceptor Y-substituents increased it.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiprotozoal Agents / chemical synthesis*
  • Benzylidene Compounds / chemical synthesis*
  • Benzylidene Compounds / pharmacology
  • Cell Death / drug effects
  • Chagas Disease / drug therapy*
  • Hydrazines / chemical synthesis*
  • Hydrazines / pharmacology
  • Models, Molecular
  • Quantitative Structure-Activity Relationship*
  • Trypanosoma cruzi / drug effects

Substances

  • Antiprotozoal Agents
  • Benzylidene Compounds
  • Hydrazines
  • carbohydrazide